UPCC 07422 Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients
Brief description of study
Please refer to Protocol Section 2.0, Study Objectives. Please refer to Protocol Sections 8.2, Primary Endpoints. Please refer to Protocol Sections 8.3, Secondary Endpoints.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age: - 99 Years
-
Gender: All
Updated on
14 Jun 2023.
Study ID: 851615
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
